• Skin of Color Savvy: Diversity in Dermatology Within the Modern Landscape, with Crystal Aguh, MD, and John Harris, MD, PhD
    2025/04/08
    In this episode of Skin of Color Savvy: The Art and Science of Treating Patients of Color, Crystal Aguh, MD, associate professor of dermatology and director of the Ethnic Skin Program at the Johns Hopkins School of Medicine, and John Harris, MD, the founding Director of the Vitiligo Clinic and Research Center, founding director of the Autoimmune Therapeutics Institute and professor and chair of the Department of Dermatology at UMass Chan Medical School in Worcester, together explored the importance of mentorship, visibility, and leadership among dermatologists and dermatology trainees of different backgrounds.
    続きを読む 一部表示
    22 分
  • Skin of Color Savvy: News Update—Debunking Myths and Highlighting the SOCS Symposium
    2025/03/27
    Skin of Color Savvy: The Art and Science of Treating Patients of Color—produced by HCPLive in collaboration with the Skin of Color Society—explores the latest research, clinical advancements, and culturally competent care practices in dermatology. Featuring Mojgan Hosseinipour, DO, FAAD, a board-certified dermatologist and clinical research investigator, this episode addresses key dermatological concerns among patients of color, misconceptions in skin health, and the importance of diversity in clinical research.

    Key Timestamps

    00:00 Introductions

    01:06 Misconceptions regarding alopecia

    02:58 Recent research involvement

    05:21 SOCS Symposium

    06:07 Dr. Elbuluk interview

    07:51 Dr. Aguh interview

    To learn more about SOCS’s mentorship programs and initiatives, visit the Skin of Color Society website: https://skinofcolorsociety.org/.
    続きを読む 一部表示
    9 分
  • Hair Loss Misconceptions, Clinical Insights, & Management, with Janiene Luke, MD, & Victoria Barbosa, MD, MPH
    2025/03/03
    In this episode of Skin of Color Savvy, Dr. Victoria Barbosa and Dr. Janiene Luke dive into hair care myths, patient habits, and managing hair loss in patients with skin of color. They discuss misconceptions about alopecia, the impact of protective styling, and the importance of cultural humility in dermatology. From diagnostic strategies to treatment options like minoxidil, PRP, and JAK inhibitors, they provide expert insights to enhance patient care. Plus, they highlight the role of hairstylists in promoting healthy hair practices. Tune in for a comprehensive discussion on improving hair loss outcomes in diverse patient populations.

    Chapters
    00:05 - Introductions
    01:52 - Misconceptions about hair loss
    03:27 - Protective hairstyling

    05:30 - Long-term commitment
    09:20 - Common types of alopecia
    11:01 - Importance of not assuming
    13:30 - Use of dermoscopy
    19:15 - Practices that exacerbate conditions
    20:40 - Topical treatment comparisons
    25:03 - Central Centrifugal Cicatricial Alopecia (CCCA)
    28:00 - Minoxidil practices
    35:29 - Advice given to patients
    39:17 - Final thoughts

    続きを読む 一部表示
    42 分
  • News Update—Addressing Disparities, Black History Month, & Mentorship Opportunities
    2025/02/18
    In this Skin of Color Savvy News Update, Dr. Brittany Oliver highlights the vital role of mentorship in dermatology and the Skin of Color Society’s (SOCS) efforts to foster professional growth. She discusses key mentorship programs, reflects on influential mentors for Black History Month, and explores the intersection of dermatology and cardiovascular health during American Heart Month. Tune in to learn how mentorship, advocacy, and systemic change can drive diversity and improve patient care.
    続きを読む 一部表示
    10 分
  • Pigmentary Disorders in Skin of Color, with Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS
    2025/02/03
    Welcome to Skin of Color Savvy: The Art and Science of Treating Patients of Color!

    In episode 2 of Skin of Color Savvy, host Nada Elbuluk, MD, chats with pigmentary disorder expert Michelle Rodrigues, MBBS, about diagnosing and managing conditions like melasma, vitiligo, and post-inflammatory hyperpigmentation in diverse populations. They discuss key diagnostic tools, systemic associations, and emerging therapies, including non-hydroquinone agents, picosecond lasers, and JAK inhibitors. The episode highlights the importance of comprehensive photoprotection, culturally competent care, and personalized treatment strategies to improve outcomes and address unique challenges in skin of color dermatology.

    Video Version only on HCPLive: CLICK HERE

    Chapters
    00:00 - Start
    02:15 - Common Pigmentary Disorders
    04:25 - Diagnostic Workup for Pigmentary Disorders
    08:35 - Labs/Blood Work for Pigmentary Disorders
    12:10 - Prevalence of Pigmentary Disorders
    14:50 - Emerging Therapies for Pigmentary Disorders
    19:45 - Conclusion


    Relevant disclosures for Elbuluk include Incyte. Rodrigues has no relevant disclosures to report.


    続きを読む 一部表示
    20 分
  • News Update—SOCS Awards, My Best Winter Skin, & TORPEDO Program
    2025/01/15
    In the inaugural Skin of Color Savvy: News Update, host Robert Brodell, MD, introduces the Skin of Color Society (SOCS) and its mission to promote excellence in skin of color dermatology. Founded in 2004 by Susan C. Taylor, MD, SOCS is a global leader with members in over 30 countries. Through its pillars of research, education, mentorship, and advocacy, SOCS is committed to advancing dermatologic care, increasing diversity in the field, and addressing the unique needs of patients with skin of color.

    Brodell highlights several SOCS initiatives designed to support innovation and diversity in dermatology. These include the Sanofi and Regeneron Diversity, Equity, and Inclusion Mid-Career Award, the Institutional Research Fellowship Grant for underrepresented minority physicians, and the Early Career Innovations Award, which fosters creative solutions in the field. SOCS also supports cutting-edge research through its annual Scientific Symposium, where experts present the latest findings in skin of color dermatology.

    The episode also introduces SOCS’s “My Best Winter Skin” campaign, launched to promote optimal winter skincare practices and raise awareness about skin health. This initiative includes an international awareness day, volunteer events, educational materials, and product donations sponsored by Clinique. Brodell encourages dermatologists to participate in outreach efforts within their communities to promote skin health and support SOCS’s broader mission.

    In the final update, Brodell shares details about TORPEDO (Training Opportunities and Residency Programs to Enhance Diversity and Outcomes), an initiative at the University of Mississippi to foster diversity in dermatology. Through mentoring, away rotations, and research opportunities, TORPEDO supports students from historically Black colleges and universities, addressing gaps in mentorship and training.

    Chapters
    00:00 - Introduction
    01:40 - SOCS Overview
    04:55 - SOCS Research Initiatives and Awards
    10:00 - My Best Winter Skin campaign
    12:55 - Training Opportunities and Residency Programs (TORPEDO) Program
    15:30 - Conclusion/Brodell Contact Info

    続きを読む 一部表示
    16 分
  • Itch in Skin of Color, with Andrew Alexis, MD, MPH, and Shawn Kwatra, MD
    2025/01/06
    Welcome to Skin of Color Savvy: The Art and Science of Treating Patients of Color, the official podcast of the Skin of Color Society, produced by HCPLive. Hosted by Skin of Color Society (SOCS) leaders, this podcast delves into the latest research, clinical insights, and culturally competent care practices in dermatology. From groundbreaking studies to practice-changing insights, we’re here to empower healthcare providers with expert perspectives on treating patients with skin of color.

    In this, the podcast’s inaugural episode, SOCS board members Andrew Alexis, MD, MPH, vice chair for Diversity and Inclusion for the Department of Dermatology and professor of Clinical Dermatology at Weill Cornell Medical College, and Shawn Kwatra, MD, associate professor of Dermatology at Johns Hopkins University School of Medicine, explore the topic of Itch in Skin of Color.

    Itch, or pruritus, in patients with skin of color presents unique challenges that are often overlooked in clinical practice. One significant issue is the lack of visible erythema, which can make it harder for clinicians to identify and assess the severity of the condition. During the conversation, Dr. Alexis emphasized that patients with darker skin tones often face delays in care due to these diagnostic challenges and cultural barriers that may prevent them from fully communicating the impact of their symptoms. He shared that targeted questions—such as asking whether itch disrupts sleep or daily focus—can be critical in uncovering the true burden of the condition.

    Kwatra highlights the need for a more tailored approach to treatment, noting that conventional therapies may not always address the specific needs of patients with darker skin tones. Topical corticosteroids, antihistamines, and other standard treatments are often prescribed, but they may not fully resolve itch in certain cases, particularly when underlying conditions like atopic dermatitis or lichen planus are involved.

    Alexis also shared his experiences with integrating newer therapeutic options, such as topical JAK inhibitors, which have shown promise in reducing itch and inflammation in this population. Together, the conversation underscored the importance of cultural competence, thorough patient history-taking, and exploring innovative therapies to address the unique challenges of itch in skin of color.

    Chapters
    00:00 - Start
    02:00 - Itch in Skin of Color
    02:30 - Kwatra’s Perspectives
    05:30 - Alexis’s Perspectives
    07:48 - Practice Pearls for Evaluating Itch
    11:30 - Therapeutic Approaches
    16:10 - Conclusion/Closing


    Relevant disclosures for Alexis include, Leo, Novartis, Menlo, Galderma, Pfizer, Sanofi-Regeneron, Dermavant, Unilever, Celgene, Beiersdorf, Valeant, L’Oreal, BMS, Menlo, Scientis, Bausch health , UCB, Foamix , Cassiopea, and Arcutis, among others. Relevant disclosures for Kwatra includeAbbvie, Amgen, Arcutis, Aslan Pharmaceuticals, Cara Therapeutics, Castle Biosciences, Celldex Therapeutics, Galderma, Incyte Corporation, Johnson & Johnson, Novartis, Leo, Regeneron, and Sanofi, among others.



    続きを読む 一部表示
    18 分